Trials / Completed
CompletedNCT01066221
Comparative Study of Three Different Testing Mechanisms for Clostridium Difficile
Comparative Study of Enzyme Immunoassays:Techlab Toxins A&B, C Diff Quick Check for Glutamate Dehydrogenase (GDH);3 PCRs,and Cytotoxin Assay (CTA) for the Detection of Clostridium Difficile Toxin in Adult Stool Specimens
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 470 (actual)
- Sponsor
- Hamilton Health Sciences Corporation · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish which of the following tests perform best in diagnosing clostridium difficile. PCR, Enzyme Immunoassays (EIA) and C. difficile cytotoxin assay (CTA).
Detailed description
This comparative study will be carried out in the hospital microbiology laboratory of a tertiary academic health center, St. Joseph's Healthcare (SJH) affiliated with McMaster University, Hamilton, ON on 500 individual stool samples from patients greater than 12 months of age to determine an efficacy of distinction between current gold standard and other methods of testing for Clostridium difficile. This study is required to find a faster test for diagnosis of CDI in order to facilitate prompt treatment and reduce the complications of CDI. Identification of infected cases will lead to the enforcement of infection control measures and thereby prevent spread to other susceptible children. This is turn will reduce costs, length of stay, morbidity, and mortality from CDI if instituted correctly.
Conditions
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-03-01
- Completion
- 2010-05-01
- First posted
- 2010-02-10
- Last updated
- 2011-07-20
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01066221. Inclusion in this directory is not an endorsement.